Literature DB >> 15853065

[The problem of multiple testing and solutions for genome-wide studies].

Balázs Gyorffy1, András Gyorffy, Zsolt Tulassay.   

Abstract

The problem of multiple testing and its solutions for genome-wide studies. Even if there is no real change, the traditional p = 0.05 can cause 5% of the investigated tests being reported significant. Multiple testing corrections have been developed to solve this problem. Here the authors describe the one-step (Bonferroni), multi-step (step-down and step-up) and graphical methods. However, sometimes a correction for multiple testing creates more problems, than it solves: the universal null hypothesis is of little interest, the exact number of investigations to be adjusted for can not determined and the probability of type II error increases. For these reasons the authors suggest not to perform multiple testing corrections routinely. The calculation of the false discovery rate is a new method for genome-wide studies. Here the p value is substituted by the q value, which also shows the level of significance. The q value belonging to a measurement is the proportion of false positive measurements when we accept it as significant. The authors propose using the q value instead of the p value in genome-wide studies.

Entities:  

Mesh:

Year:  2005        PMID: 15853065

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  21 in total

1.  Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.

Authors:  Riad Salem; Robert J Lewandowski; Laura Kulik; Edward Wang; Ahsun Riaz; Robert K Ryu; Kent T Sato; Ramona Gupta; Paul Nikolaidis; Frank H Miller; Vahid Yaghmai; Saad M Ibrahim; Seanthan Senthilnathan; Talia Baker; Vanessa L Gates; Bassel Atassi; Steven Newman; Khairuddin Memon; Richard Chen; Robert L Vogelzang; Albert A Nemcek; Scott A Resnick; Howard B Chrisman; James Carr; Reed A Omary; Michael Abecassis; Al B Benson; Mary F Mulcahy
Journal:  Gastroenterology       Date:  2010-10-30       Impact factor: 22.682

2.  Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis.

Authors:  Khairuddin Memon; Laura Kulik; Robert J Lewandowski; Edward Wang; Robert K Ryu; Ahsun Riaz; Paul Nikolaidis; Frank H Miller; Vahid Yaghmai; Talia Baker; Michael Abecassis; Al B Benson; Mary F Mulcahy; Reed A Omary; Riad Salem
Journal:  J Hepatol       Date:  2012-01-13       Impact factor: 25.083

3.  Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times.

Authors:  Khairuddin Memon; Laura Kulik; Robert J Lewandowski; Edward Wang; Ahsun Riaz; Robert K Ryu; Kent T Sato; Karen Marshall; Ramona Gupta; Paul Nikolaidis; Frank H Miller; Vahid Yaghmai; Seanthan Senthilnathan; Talia Baker; Vanessa L Gates; Michael Abecassis; Al B Benson; Mary F Mulcahy; Reed A Omary; Riad Salem
Journal:  Gastroenterology       Date:  2011-04-30       Impact factor: 22.682

4.  Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes.

Authors:  Khairuddin Memon; Robert J Lewandowski; Mary F Mulcahy; Ahsun Riaz; Robert K Ryu; Kent T Sato; Ramona Gupta; Paul Nikolaidis; Frank H Miller; Vahid Yaghmai; Vanessa L Gates; Bassel Atassi; Steven Newman; Reed A Omary; Al B Benson; Riad Salem
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-02       Impact factor: 7.038

5.  Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy.

Authors:  Robert J Lewandowski; Khairuddin Memon; Mary F Mulcahy; Ryan Hickey; Karen Marshall; Melissa Williams; Krystina Salzig; Vanessa L Gates; Bassel Atassi; Michael Vouche; Rohi Atassi; Kush Desai; Elias Hohlastos; Kent Sato; Ali Habib; Sheetal Kircher; Steven B Newman; Halla Nimeiri; Al B Benson; Riad Salem
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-06-07       Impact factor: 9.236

6.  Dietary Fat Intake During Adolescence and Breast Density Among Young Women.

Authors:  Seungyoun Jung; Olga Goloubeva; Catherine Klifa; Erin S LeBlanc; Linda G Snetselaar; Linda Van Horn; Joanne F Dorgan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-19       Impact factor: 4.254

7.  Liver-specific hepatocyte nuclear factor-4alpha deficiency: greater impact on gene expression in male than in female mouse liver.

Authors:  Minita G Holloway; Gregory D Miles; Alan A Dombkowski; David J Waxman
Journal:  Mol Endocrinol       Date:  2008-02-14

8.  Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary results.

Authors:  Zhongzhi Jia; Ricardo Paz-Fumagalli; Gregory Frey; David M Sella; J Mark McKinney; Weiping Wang
Journal:  J Cancer Res Clin Oncol       Date:  2016-11-08       Impact factor: 4.553

9.  Assess the effects of culturally relevant intervention on breast cancer knowledge, beliefs, and mammography use among Korean American women.

Authors:  Jin Hee Kim; Usha Menon; Edward Wang; Laura Szalacha
Journal:  J Immigr Minor Health       Date:  2009-04-17

10.  APOB Genotypes and CDH13 Haplotypes in the Cholesterol-Related Pathway Genes Predict Non-Small Cell Lung Cancer Survival.

Authors:  Wei Deng; Hongliang Liu; Sheng Luo; Jeffrey Clarke; Carolyn Glass; Li Su; Lijuan Lin; David C Christiani; Qingyi Wei
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-04-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.